- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Regeneron Pharmaceuticals Inc+ Add to Watchlist
REGN:US513.810 USD 1.250 0.24%
As of 20:10:00 ET on 06/01/2015.
Company Profile for Regeneron Pharmaceuticals Inc (REGN)
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
Regeneron Pharmaceuticals Inc
Key Executives for Regeneron Pharmaceuticals Inc (REGN)
|Leonard S Schleifer "Len"President/CEO/Co-Founder||George D YancopoulosPres:Laboratories|
|Neil StahlExec VP:Research & Development||Joseph J Larosa "Joe"Senior VP/Secy/General Counsel|
|Daniel P Van PlewSenior VP/Gen Mgr:Industrial Ops||Robert E Landry Jr "Bob"Senior VP:Finance/CFO|
|Robert J TerifaySenior VP:Commercial||Peter PowchikSenior VP:Clinical Development|
|Michael AbermanSenior VP:Strategy & IR||Douglas S McCorkleVP/Asst Treasurer/Controller|